Does the use of Eri-Ppi lead to increased risk of fractures?
Nov 4, 2023
Does the use of Eri-Ppi lead to increased risk of fractures?
Multiple studies conducted in adults have provided evidence suggesting a potential connection between the usage of EriPpi and an elevated risk of fractures related to osteoporosis particularly affecting the hip wrist and spine It has been observed that patients who were administered high doses of this medication faced a greater likelihood of experiencing fractures The term high dose refers to the administration of multiple daily doses over an extended period typically lasting a year or more The findings of these studies have raised concerns regarding the potential adverse effects of EriPpi on bone health Osteoporosisrelated fractures can lead to significant health complications and reduced quality of life for individuals affected by this condition Therefore it is crucial for healthcare professionals to carefully assess the risks and benefits associated with EriPpi treatment especially in patients who may already have an increased vulnerability to fractures As further research is conducted in this area it is important to consider alternative treatment options or modifications to dosage regimens for patients who may be susceptible to osteoporosisrelated fractures By doing so healthcare providers can ensure the safety and wellbeing of their patients while effectively managing their medical conditions
Medicines
For information purposes only. Consult a doctor before taking any medicines.
₹130₹260
₹237₹263
₹189₹210
₹144₹160
₹328₹365
₹146₹162
₹255₹283
₹111₹123
₹135₹150